ethnopharmacolog
relev
licoric
glycyrrhiza
uralensi
fisch
leguminosa
use
herbal
medicin
food
supplement
worldwid
centuri
licoric
common
ingredi
sever
prescript
tradit
chines
medicin
prove
inhibit
infect
human
respiratori
syncyti
viru
hrsv
two
prepar
licoric
radix
glycyrrhiza
radix
glycyrrhiza
preparata
howev
unknown
whether
licoric
prepar
licoric
effect
hrsv
activ
constitu
aim
studi
test
hypothesi
radix
glycyrrhiza
effect
decreas
hrsvinduc
plaqu
format
respiratori
mucos
cell
line
also
tri
find
activ
constitu
materi
method
antihrsv
activ
hot
water
extract
prepar
licoric
glycyrrhizin
acid
activ
constitu
licoric
examin
plaqu
reduct
assay
human
upper
low
respiratori
tract
cell
line
abil
crude
licoric
inhibit
viral
replic
stimul
evalu
revers
transcript
polymeras
chain
reaction
rtpcr
enzymelink
immunosorb
assay
elisa
respect
result
radix
glycyrrhiza
radix
glycyrrhiza
preparata
dosedepend
inhibit
hrsvinduc
plaqu
format
cell
line
po
effect
radix
glycyrrhiza
better
radix
glycyrrhiza
preparata
cell
howev
differ
antihrsv
effect
cell
besid
glycyrrhizin
ineffect
nevertheless
show
potent
antihrsv
activ
radix
glycyrrhiza
effect
given
viral
inocul
po
may
due
inhibit
viral
attach
po
penetr
po
host
cell
antihrsv
activ
radix
glycyrrhiza
confirm
rtpcr
qrtpcr
radix
glycyrrhiza
markedli
decreas
viral
amount
within
cell
suspens
radix
glycyrrhiza
might
stimul
mucos
cell
secret
counteract
viral
infect
conclus
radix
glycyrrhiza
radix
glycyrrhiza
preparata
effect
hrsv
infect
airway
epitheli
cell
radix
glycyrrhiza
inhibit
hrsv
mainli
prevent
viral
attach
intern
stimul
ifn
secret
may
one
activ
constitu
ethnopharmacolog
relev
licoric
glycyrrhiza
uralensi
fisch
leguminosa
use
herbal
medicin
food
supplement
worldwid
centuri
licoric
common
ingredi
sever
prescript
tradit
chines
medicin
prove
inhibit
infect
human
respiratori
syncyti
viru
hrsv
two
prepar
licoric
radix
glycyrrhiza
radix
glycyrrhiza
preparata
howev
unknown
whether
licoric
prepar
licoric
effect
hrsv
activ
constitu
aim
studi
test
hypothesi
radix
glycyrrhiza
effect
decreas
hrsvinduc
plaqu
format
respiratori
mucos
cell
line
also
tri
find
activ
constitu
materi
method
antihrsv
activ
hot
water
extract
prepar
licoric
glycyrrhizin
acid
activ
constitu
licoric
examin
plaqu
reduct
assay
human
upper
low
respiratori
tract
cell
line
abil
crude
licoric
inhibit
viral
replic
stimul
evalu
revers
transcript
polymeras
chain
reaction
rtpcr
enzymelink
immunosorb
assay
elisa
respect
result
radix
glycyrrhiza
radix
glycyrrhiza
preparata
dosedepend
inhibit
hrsvinduc
plaqu
format
cell
line
po
effect
radix
glycyrrhiza
better
radix
glycyrrhiza
preparata
cell
howev
differ
antihrsv
effect
cell
besid
glycyrrhizin
ineffect
nevertheless
show
potent
antihrsv
activ
radix
glycyrrhiza
effect
given
viral
inocul
po
may
due
inhibit
viral
attach
po
penetr
po
host
cell
antihrsv
activ
radix
glycyrrhiza
confirm
rtpcr
qrtpcr
radix
glycyrrhiza
markedli
decreas
viral
amount
within
cell
suspens
radix
glycyrrhiza
might
stimul
mucos
cell
secret
counteract
viral
infect
conclus
radix
glycyrrhiza
radix
glycyrrhiza
preparata
effect
hrsv
infect
airway
epitheli
cell
radix
glycyrrhiza
inhibit
hrsv
mainli
prevent
viral
attach
intern
stimul
ifn
secret
may
one
activ
constitu
elsevi
ireland
ltd
right
reserv
viral
bronchiol
pneumonia
common
low
respiratori
tract
infect
infant
children
year
age
bronchiol
could
caus
respiratori
failur
infant
children
abboud
et
al
jat
chawla
human
respiratori
syncyti
viru
hrsv
rather
influenza
viru
import
caus
viral
bronchiol
macao
et
al
furthermor
hrsv
major
pathogen
viral
pneumonia
children
falad
ayed
incid
hrsvinduc
pneumonia
six
time
influenza
viru
children
year
age
hatipoglu
et
al
estim
million
children
younger
year
old
annual
die
pneumonia
worldwid
maxwel
et
al
therefor
hrsv
common
caus
hospit
due
sever
acut
low
respiratori
infect
infant
children
nair
et
al
ribavirin
fdaapprov
agent
manag
hrsv
infect
howev
ribavirin
continu
inhal
h
get
therapeut
effect
inconveni
use
shigeta
applic
ribavirin
limit
side
effect
de
franceschi
et
al
empey
et
al
therefor
american
academi
pediatr
recommend
ribavirin
manag
hrsv
infect
empey
et
al
palivizumab
human
monoclon
igg
antibodi
hrsv
effect
prevent
hrsv
infect
nevertheless
expens
ineffect
manag
establish
hrsv
infect
shadman
wald
develop
new
antihrsv
chemotherapi
urgent
need
licoric
glycyrrhiza
uralensi
fisch
leguminosa
common
ingredi
prescript
tradit
chines
medicin
gegentang
ggt
kakkonto
chang
et
al
liuhetang
lht
chang
et
al
shengmagegentang
smggt
shomakakkonto
wang
et
al
chines
tradit
prescript
airway
symptom
prove
antihrsv
activ
prescript
contain
glycyrrhiza
uralensi
therefor
hypothes
glycyrrhiza
uralensi
might
one
activ
ingredi
account
antihrsv
activ
howev
glycyrrhiza
uralensi
also
common
ingredi
numer
chines
tradit
prescript
therefor
might
bystand
coincident
present
within
prescript
besid
two
prepar
chines
licoric
one
crude
licoric
radix
glycyrrhiza
honeyburn
process
licoric
radix
glycyrrhiza
preparata
radix
glycyrrhiza
praeparata
cum
mell
radix
glycyrrhiza
use
manag
variou
symptom
differ
organ
system
worldwid
includ
sore
throat
infecti
diseas
fior
et
al
shi
et
al
extract
radix
glycyrrhiza
activ
constitu
report
anticanc
activ
seon
et
al
organprotect
effect
kim
et
al
zhang
et
al
protect
heavi
metal
injuri
kim
et
al
antioxid
antiinflammatori
activ
chin
et
al
wu
et
al
vitro
antivir
activ
radix
glycyrrhiza
report
human
immunodefici
viru
sasaki
et
al
japanes
enceph
viru
badam
kuo
et
al
rotaviru
kwon
et
al
sarsassoci
coronaviru
cinatl
et
al
epsteinbarr
viru
lin
flavivirus
cranc
et
al
antivir
activ
hrsv
report
hela
cell
dong
et
al
wang
et
al
howev
hela
cell
respiratori
tract
cell
actual
antihrsv
activ
radix
glycyrrhiza
question
contrast
radix
glycyrrhiza
preparata
commonli
use
manag
weak
palpit
howev
studi
radix
glycyrrhiza
preparata
rare
bioactiv
fulli
understood
bioactiv
crude
medicin
plant
chang
prepar
exampl
dri
ginger
prepar
fresh
ginger
loos
antihrsv
activ
process
chang
et
al
therefor
interest
know
whether
radix
glycyrrhiza
radix
glycyrrhiza
preparata
antivir
activ
hrsv
use
human
upper
low
respiratori
tract
cell
line
test
hypothesi
radix
glycyrrhiza
radix
glycyrrhiza
preparata
could
effect
inhibit
plaqu
format
induc
hrsv
infect
also
examin
antihrsv
activ
constitu
airdri
root
glycyrrhiza
uralensi
collect
market
south
taiwan
voucher
specimen
prepar
deposit
kaohsiung
medic
univers
kmu
herbarium
authent
examin
expert
least
twice
morpholog
anatom
identif
furthermor
reverseperform
liquid
chromatographi
use
establish
hplc
fingerprint
confirm
perform
hyperclon
od
c
column
phosphor
acid
select
mobil
phase
gradient
elut
hplc
fingerprint
data
show
standard
glycyrrhizin
ammonium
salt
retent
time
nearbi
min
one
major
constitu
licoric
fig
fingerprint
similar
root
glycyrrhiza
uralensi
fisch
wang
yang
furthermor
content
liquiritin
retent
time
nearbi
min
shown
much
less
glycyrrhizin
glycyrrhiza
glabra
glycyrrhiza
inflat
rauchenstein
et
al
hplc
fingerprint
data
fig
confirm
airdri
root
use
glycyrrhiza
glabra
g
inflat
hot
water
extract
crude
licoric
radix
glycyrrhiza
prepar
report
chang
et
al
weight
weight
ww
yield
radix
glycyrrhiza
preparata
prepar
slice
crude
licoric
mix
well
honey
heat
small
fire
color
turn
golden
deep
yellow
hot
water
extract
prepar
ww
yield
extract
licoric
dissolv
dulbecco
modifi
eagl
medium
dmem
gibco
brl
ny
supplement
fetal
calf
serum
fc
final
concentr
bioactiv
assay
cytotox
test
experi
human
airway
mucos
cell
line
human
larynx
epidermoid
carcinoma
cell
atcc
ccl
cell
human
lung
carcinoma
cell
atcc
use
inocul
human
respiratori
syncyti
viru
hrsv
long
strain
atcc
cell
propag
c
co
dmem
supplement
fetal
calf
serum
fc
antibiot
fc
instead
use
cultur
virusinfect
cell
monolay
glycyrrhizin
sigma
mo
main
activ
constitu
glycyrrhiza
uralensi
acid
sigma
mo
activ
constitu
licoric
also
primari
metabolit
glycyrrhizin
also
test
viru
store
titer
determin
plaqu
assay
express
plaqu
form
unit
per
ml
pfuml
cytotox
glycyrrhizin
differ
prepar
licoric
cell
assay
xttbase
method
wang
et
al
briefli
well
cell
seed
cultur
plate
incub
overnight
co
cultur
medium
replac
differ
concentr
prepar
licoric
triplic
day
incub
cytotox
determin
xtt
sodium
phenylaminocarbonyl
bi
benzen
sulfon
acid
kit
roch
germani
cytotox
concentr
cc
calcul
regress
analysi
doserespons
curv
gener
data
antivir
activ
glycyrrhizin
differ
prepar
licoric
examin
plaqu
reduct
assay
wang
et
al
briefli
well
cell
plate
cultur
plate
h
inocul
mixtur
pfuwel
hrsv
variou
concentr
glycyrrhizin
differ
prepar
licoric
triplic
h
ribavirin
sigma
mo
posit
control
cell
cover
overlay
medium
dmem
plu
fc
methylcellulos
cultur
co
day
cell
monolay
fix
stain
plaqu
count
minim
concentr
requir
inhibit
cytopath
effect
ic
calcul
regress
analysi
doserespons
curv
gener
data
select
index
si
calcul
ratio
antivir
activ
radix
glycyrrhiza
examin
plaqu
reduct
assay
viral
inocul
wang
et
al
briefli
cell
seed
incub
h
previous
describ
radix
glycyrrhiza
variou
concentr
supplement
triplic
h
h
viral
inocul
h
h
viral
inocul
h
h
h
h
viral
inocul
supernat
replac
overlay
medium
incub
anoth
h
mention
fixat
stain
plaqu
count
plaqu
reduct
assay
appli
evalu
effect
radix
glycyrrhiza
viral
attach
wang
et
al
briefli
cell
seed
incub
h
cell
prechil
h
medium
replac
mixtur
hrsv
pfuwel
variou
concentr
radix
glycyrrhiza
incub
anoth
h
free
viru
remov
cell
monolay
wash
icecold
phosphatebuff
salin
pb
three
time
cover
overlay
medium
incub
co
h
examin
plaqu
assay
describ
earlier
effect
radix
glycyrrhiza
viral
intern
also
evalu
wang
et
al
briefli
cell
seed
cultur
plate
incub
h
prechil
h
cell
infect
pfuwel
hrsv
incub
anoth
h
viruscontain
medium
replac
fresh
medium
contain
variou
concentr
radix
glycyrrhiza
triplic
shift
cultur
interv
follow
shift
unintern
viru
inactiv
supplement
acid
pb
ph
min
follow
alkalin
pb
ph
neutral
pb
replac
fresh
overlay
medium
incub
h
cell
monolay
examin
plaqu
assay
describ
earlier
revers
transcript
polymeras
chain
reaction
rtpcr
quantit
rtpcr
qrtpcr
antivir
activ
licoric
examin
rtpcr
quantit
semiquantit
briefli
well
cell
plate
cultur
plate
h
mixtur
pfuwel
hrsv
variou
concentr
licoric
supplement
procedur
mention
ribavirin
sigma
mo
posit
control
cultur
h
viral
rna
extract
rneasi
plu
mini
kit
qiagen
germani
qiaamp
viral
rna
mini
kit
qiagen
germani
hrsvinfect
cell
cultur
supernat
respect
cdna
synthes
elut
rna
use
superscript
ii
rnase
h
revers
transcriptas
kit
invitrogen
ca
briefli
rna
supplement
cdna
synthesi
master
mixtur
contain
revers
transcriptas
dtt
mm
dntp
hrsv
revers
primer
bannist
et
al
reaction
carri
min
follow
min
cdna
supplement
reaction
tube
contain
taq
master
mix
vivanti
ca
hrsv
forward
primer
agcaaatacaccatc
rever
primer
supplement
nucleasefre
water
total
volum
pcr
condit
min
follow
cycl
amplif
follow
final
extens
min
amplif
product
analyz
semiquantit
agaros
gel
electrophoresi
quantit
pcr
cdna
supplement
reaction
tube
contain
fast
sybr
green
master
mix
appli
biosystem
ca
hrsv
primer
supplement
nucleasefre
water
total
volum
quantit
pcr
condit
min
follow
cycl
amplif
step
one
realtim
pcr
system
appli
biosystem
ca
ethidium
bromid
stain
band
gel
electrophoresi
visibl
expect
molecular
weight
rel
viral
amount
experiment
group
calcul
deltadeltact
threshold
cycl
deriv
differ
ct
viral
control
experiment
group
experi
antivir
effect
assay
mention
cultur
medium
collect
assay
elisa
kit
pbl
biomed
md
elisa
kit
r
system
mn
accord
manufactur
instruct
nm
determin
elisa
reader
mutiskan
ex
labsystem
result
express
mean
standard
deviat
sd
percentag
control
infect
rate
calcul
plaqu
count
experiment
group
divid
viral
control
data
analyz
anova
jmp
softwar
sa
nc
tukey
honestli
signific
differ
hsd
test
use
compar
pair
group
anova
test
p
consid
statist
signific
water
extract
radix
glycyrrhiza
radix
glycyrrhiza
preparata
welltoler
cell
cytotox
found
concentr
fig
estim
cc
radix
glycyrrhiza
radix
glycyrrhiza
preparata
cell
cell
respect
glycyrrhizin
show
cytotox
host
cell
concentr
fig
howev
show
cytotox
concentr
higher
fig
estim
cc
cell
radix
glycyrrhiza
radix
glycyrrhiza
preparata
fig
p
ribavirin
fig
p
dosedepend
effect
hrsv
cell
effect
radix
glycyrrhiza
show
differ
cell
cell
fig
contrast
radix
glycyrrhiza
preparata
better
cell
fig
antihrsv
activ
radix
glycyrrhiza
radix
glycyrrhiza
preparata
similar
cell
fig
therefor
radix
glycyrrhiza
better
effect
cell
radix
glycyrrhiza
preparata
fig
p
calcul
ic
radix
glycyrrhiza
cell
cell
calcul
ic
radix
glycyrrhiza
preparata
cell
cell
glycyrrhizin
wellknown
activ
constitu
licoric
effect
fig
howev
dosedepend
effect
hrsv
cell
fig
po
calcul
ic
cell
cell
si
radix
glycyrrhiza
cell
respect
si
radix
glycyrrhiza
preparata
cell
respect
si
cell
cell
radix
glycyrrhiza
radix
glycyrrhiza
preparata
effect
hrsv
radix
glycyrrhiza
use
go
experi
radix
glycyrrhiza
timedepend
dosedepend
effect
hrsv
fig
cell
fig
p
radix
glycyrrhiza
effect
mainli
supplement
viral
inocul
fig
p
better
effect
cell
p
calcul
ic
h
h
cell
h
h
cell
respect
fact
antihrsv
activ
mainli
supplement
viral
inocul
radix
glycyrrhiza
suppos
work
viral
attach
andor
intern
result
attach
assay
confirm
assumpt
radix
glycyrrhiza
dosedepend
effect
viral
attach
fig
p
especi
cell
po
result
consist
antivir
effect
assay
fig
time
cours
assay
fig
calcul
ic
cell
cell
result
intern
assay
also
consist
assay
fig
radix
glycyrrhiza
timedepend
dosedepend
effect
inhibit
viral
penetr
fig
po
better
effect
cell
p
effect
slight
wors
attach
assay
calcul
ic
min
min
min
cell
min
min
min
cell
respect
result
semiquantif
viral
rna
agaros
gel
electrophoresi
fig
compar
quantit
rtpcr
fig
radix
glycyrrhiza
markedli
decreas
viral
amount
within
cell
suspens
carryov
amplif
product
viral
control
group
cell
control
group
load
sampl
note
fig
radix
glycyrrhiza
dosedepend
stimul
cell
secret
fig
p
without
hrsv
infect
contrast
secret
radix
glycyrrhiza
affect
secret
without
viral
infect
fig
actual
radix
glycyrrhiza
high
concentr
may
inhibit
secret
studi
surpris
radix
glycyrrhiza
radix
glycyrrhiza
preparata
effect
inhibit
hrsvinduc
plaqu
format
cell
therefor
antihrsv
activ
licoric
chang
prepar
process
contrast
ginger
whose
antihrsv
activ
lost
process
chang
et
al
radix
glycyrrhiza
antihrsv
activ
better
activ
inhibit
viral
attach
intern
antihrsv
activ
radix
glycyrrhiza
confirm
rtpcr
qrtpcr
besid
radix
glycyrrhiza
high
concentr
could
stimul
secret
multipl
antivir
activ
includ
inhibit
viral
penetr
uncoat
mrna
translat
protein
synthesi
genom
replic
viru
assembl
releas
counteract
viral
infect
sen
hrsv
caus
mortal
morbid
mainli
patholog
low
respiratori
tract
radix
glycyrrhiza
radix
glycyrrhiza
preparata
effect
hrsv
low
airway
mucos
cell
minim
lung
injuri
fig
therefor
studi
support
use
radix
glycyrrhiza
radix
glycyrrhiza
preparata
certain
prescript
tradit
chines
medicin
hrsv
infect
radix
glycyrrhiza
better
effect
cell
upper
airway
mucos
cell
line
fig
wonder
radix
glycyrrhiza
rather
radix
glycyrrhiza
preparata
use
manag
sore
throat
orient
centuri
radix
glycyrrhiza
report
inhibit
hrsvinduc
cytopath
effect
cpe
hela
cell
dong
et
al
cell
et
al
hela
cell
cervic
cell
line
appropri
exam
respiratori
tract
injuri
although
cpe
effect
hrsv
could
reduc
radix
glycyrrhiza
cell
et
al
direct
microscop
examin
cpe
gold
standard
studi
antivir
activ
wherea
plaqu
reduct
assay
studi
use
plaqu
reduct
assay
provid
valid
result
support
radix
glycyrrhiza
antihrsv
activ
cell
besid
plaqu
reduct
assay
clearli
show
mode
action
also
result
show
consist
differ
assay
differ
respiratori
tract
cell
line
therefor
studi
provid
solid
evid
support
licoric
antihrsv
activ
glycyrrhizin
major
activ
constitu
radix
glycyrrhiza
activ
hrsv
activ
constitu
licoric
also
primari
metabolit
glycyrrhizin
convert
gut
commens
bacteria
hendrick
et
al
effect
hrsvinduc
plaqu
format
fig
therefor
antihrsv
activ
radix
glycyrrhiza
could
directli
mediat
could
augment
bacteri
convers
glycyrrhizin
gut
report
antivir
activ
rotaviru
hardi
et
al
epsteinbarr
viru
lin
et
al
studi
demonstr
first
time
also
activ
hrsv
infect
antiinflammatori
activ
inhibit
activ
reduc
product
inflammatori
cytokin
wang
et
al
therefor
inhibit
hrsv
hrsvinduc
inflammatori
respons
could
activ
constitu
mediat
vivo
antihrsv
activ
licoric
therefor
suppos
may
one
activ
constitu
account
antihrsv
activ
licoric
howev
antivir
mechan
still
unclear
mani
work
need
done
futur
conclus
radix
glycyrrhiza
radix
glycyrrhiza
preparata
antihrsv
activ
prevent
cytopathi
airway
epithelia
radix
glycyrrhiza
decreas
hrsv
infect
larg
inhibit
viral
attach
intern
stimul
ifn
secret
acid
might
one
activ
constitu
account
antihrsv
activ
licoric
